In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.
The Telegraph reports that philosopher Jeremy Bentham is to have his DNA tested.
Researchers have increased their estimate of the heritability of ASD to 83 percent based on a reanalysis of their prior study of Swedish families.
The grants include awards for projects using genetics to identify differences in how ASD affects boys versus girls, and how to improve treatments.
Researchers found 7 percent of mutations in children's DNA could be traced to postzygotic mosaic mutations present early in their parents' embryonic development.
Investigators identified ties between autism spectrum disorder and mitochondrial haplogroups in mtDNA variant data from nearly 1,000 ASD-affected families.
In PNAS this week: deep evolutionary conservation of autism-linked genes, cytokine signature of chronic fatigue syndrome, and more.
The company is collaborating with hospitals to implement sequencing and machine learning approaches to pinpoint the molecular etiology of autism earlier in age.
In PNAS this week: analytical method for assessing shared variants, treatment targets in hereditary pancreatic cancer, and more.
Spectrum News reports that a group has uncovered a statistical flaw in a recent paper linking new genes to autism or developmental delay.
A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.
The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.
Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.
In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.